Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1982 1
1983 1
1985 1
1986 1
1987 2
1988 3
1989 3
1990 2
1991 2
1992 2
1993 9
1994 5
1995 3
1996 4
1997 3
1998 4
1999 8
2000 5
2001 4
2002 4
2003 5
2004 12
2005 3
2006 3
2007 3
2008 7
2009 8
2010 2
2011 7
2012 4
2013 6
2014 4
2015 6
2016 4
2017 5
2018 8
2019 2
2020 3
2021 2
2022 3
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 0606400
Page 1
Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models.
Chen X, Tao Z, Liang Y, Ma M, Adah D, Ding W, Chen L, Li X, Dai L, Fanuel S, Zhao S, Hu W, Wu D, Duan Z, Zhou F, Qin L, Chen X, Yang Z. Chen X, et al. Front Oncol. 2023 Oct 17;13:1181176. doi: 10.3389/fonc.2023.1181176. eCollection 2023. Front Oncol. 2023. PMID: 37916167 Free PMC article.
Therefore, we tested whether Plasmodium immunotherapy combined with gemcitabine (Gem), a representative chemotherapy drug, has synergistic antitumor effects. METHODS: We designed subcutaneously and intravenously implanted murine Lewis lung cancer (LLC) models to test the a …
Therefore, we tested whether Plasmodium immunotherapy combined with gemcitabine (Gem), a representative chemotherapy drug, has synerg …
Babesia microti Confers Macrophage-Based Cross-Protective Immunity Against Murine Malaria.
Efstratiou A, Galon EMS, Wang G, Umeda K, Kondoh D, Terkawi MA, Kume A, Liu M, Ringo AE, Guo H, Gao Y, Lee SH, Li J, Moumouni PFA, Nishikawa Y, Suzuki H, Igarashi I, Xuan X. Efstratiou A, et al. Front Cell Infect Microbiol. 2020 Apr 29;10:193. doi: 10.3389/fcimb.2020.00193. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32411624 Free PMC article.
Simultaneous infection with both pathogens led to high mortality rates in immunocompetent BALB/c mice, similar to control mice infected with P. chabaudi alone. On the other hand, mice with various stages of B. microti primary infection were thoroughly immune to a su …
Simultaneous infection with both pathogens led to high mortality rates in immunocompetent BALB/c mice, similar to control mice infect …
Mistimed malaria parasites re-synchronize with host feeding-fasting rhythms by shortening the duration of intra-erythrocytic development.
O'Donnell AJ, Greischar MA, Reece SE. O'Donnell AJ, et al. Parasite Immunol. 2022 Mar;44(3):e12898. doi: 10.1111/pim.12898. Epub 2021 Nov 22. Parasite Immunol. 2022. PMID: 34778983 Free PMC article. Review.
We compare how the duration, synchrony and timing of the IDC differs between parasites in control infections and those forced to reschedule by 12 hours and ask whether the density of parasites affects the rescheduling process. ...
We compare how the duration, synchrony and timing of the IDC differs between parasites in control infections and those forced to resc …
Plasmodium vivax and Plasmodium chabaudi: intraerythrocytic traffic of antigenically homologous proteins involves a brefeldin A-sensitive secretory pathway.
Bracho C, Dunia I, Romano M, Benedetti EL, Perez HA. Bracho C, et al. Eur J Cell Biol. 2001 Feb;80(2):164-70. doi: 10.1078/0171-9335-00137. Eur J Cell Biol. 2001. PMID: 11302521
We have used a monoclonal antibody (mAb 7C5B71) raised against the erythrocytic stages of Plasmodium vivax to identify a 148-kDa P vivax protein antigen (Pv-148) which crossreacts with an antigenically homologous 190-kDa protein of P. chabaudi (Pc …
We have used a monoclonal antibody (mAb 7C5B71) raised against the erythrocytic stages of Plasmodium vivax to identify a 148-kDa P vi …
Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization.
Nahrendorf W, Spence PJ, Tumwine I, Lévy P, Jarra W, Sauerwein RW, Langhorne J. Nahrendorf W, et al. Elife. 2015 Feb 25;4:e05165. doi: 10.7554/eLife.05165. Elife. 2015. PMID: 25714922 Free PMC article.
We established a new mouse model of CPS immunization to investigate the stage and strain-specificity of malaria immunity. Immunization with Plasmodium chabaudi by mosquito bite under chloroquine cover does not generate pre-erythrocytic immunity, which is acquired on …
We established a new mouse model of CPS immunization to investigate the stage and strain-specificity of malaria immunity. Immunization with …
Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM Jr, Flaherty PR, Nanavati P, Weidanz WP. Burns JM Jr, et al. Infect Immun. 2004 Oct;72(10):5605-12. doi: 10.1128/IAI.72.10.5605-5612.2004. Infect Immun. 2004. PMID: 15385457 Free PMC article.
In the present study, we evaluated the contribution of antibody-mediated and cell-mediated immune mechanisms to the protection induced by immunization with two blood-stage malaria vaccine candidate antigens, apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 …
In the present study, we evaluated the contribution of antibody-mediated and cell-mediated immune mechanisms to the protection induced by im …
Immunity to erythrocytic stages of malarial parasites.
Long CA, Daly TM, Kima P, Srivastava I. Long CA, et al. Am J Trop Med Hyg. 1994;50(4 Suppl):27-32. doi: 10.4269/ajtmh.1994.50.27. Am J Trop Med Hyg. 1994. PMID: 7909653 Review.
Moreover, these models allow identification of plasmodial molecules that can induce different types of host responses. Two different mouse model systems, Plasmodium yoelii yoelii and P. chabaudi adami are presented. These have been selected because resolution of inf …
Moreover, these models allow identification of plasmodial molecules that can induce different types of host responses. Two different mouse m …
BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.
Tangie E, Walters A, Hsu NJ, Fisher M, Magez S, Jacobs M, Keeton R. Tangie E, et al. Immunology. 2022 Feb;165(2):219-233. doi: 10.1111/imm.13431. Epub 2021 Dec 6. Immunology. 2022. PMID: 34775598 Free article.
Given the geographical overlap of malaria and TB in areas where BCG vaccination is routinely administered, we hypothesized that virulence-dependent co-infection with Plasmodium species could alter the BCG-specific immune responses thus resulting in failure to protect again …
Given the geographical overlap of malaria and TB in areas where BCG vaccination is routinely administered, we hypothesized that virulence-de …
Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM Jr, Flaherty PR, Romero MM, Weidanz WP. Burns JM Jr, et al. Vaccine. 2003 May 16;21(17-18):1843-52. doi: 10.1016/s0264-410x(03)00026-4. Vaccine. 2003. PMID: 12706668
We have utilized a Plasmodium chabaudi vaccine model to begin to evaluate the efficacy of immunization with combined formulations of apical membrane antigen-1 (AMA-1) and merozoite surface protein-1 (MSP-1). ...Based on the reduction of P. chabaudi par …
We have utilized a Plasmodium chabaudi vaccine model to begin to evaluate the efficacy of immunization with combined formulati …
Transformation of the rodent malaria parasite Plasmodium chabaudi.
Spence PJ, Cunningham D, Jarra W, Lawton J, Langhorne J, Thompson J. Spence PJ, et al. Nat Protoc. 2011 Apr;6(4):553-561. doi: 10.1038/nprot.2011.313. Epub 2011 Mar 31. Nat Protoc. 2011. PMID: 21455190 Free PMC article.
The rodent malaria parasite Plasmodium chabaudi chabaudi shares many features with human malaria species, including P. falciparum, and is the in vivo model of choice for many aspects of malaria research in the mammalian host, from sequestration of parasitized …
The rodent malaria parasite Plasmodium chabaudi chabaudi shares many features with human malaria species, including P. …
157 results